Table 1. Major Differential Lipids and Metabolites between Individual Cell Marker Typesa.
| CD31 | CD68 | CD20 | histone | pancytoleratin | Ki67 | |
|---|---|---|---|---|---|---|
| CD68 | NAPE(58:5p) | |||||
| CL 72:8 | ||||||
| CL 76:11 | ||||||
| citrate/isocitrate | ||||||
| GM3(16:0h) | ||||||
| CD20 | NAPE(58:5p) | LysoPA(16:0) [M–H2O–M] | ||||
| CL 76:11 | GM3(24h:0) | |||||
| CL 78:13 | PEp 40:6 | |||||
| hexose | PE 36:3 | |||||
| arginine | LysoPA 18:1 [M–H2O–M] | |||||
| histone | CL 72:8 | PE 36:3 | PE 36:3 | |||
| NAPE(58:5p) | PI 40:6 | GM3(24h:0) | ||||
| PI 40:6 | GM3(24:0) | FA_C22:5 | ||||
| hexose monophosphate [M–H] | citrate/isocitrate | citrate/isocitrate | ||||
| PA(38:3) | LysoPSp 18:1 | NAPE(52:5p) | ||||
| PI 40:6 | PS 38:4 | PI 34:1 | PE 34:1 | |||
| pancytoleratin | CL 72:8 | LysoPA(16:0) [M–H2O–M] | PI 36:1 | PS 38:4 | ||
| hexose monophosphate [M–H] | PI 40:6 | PI 40:6 | PI 40:6 | |||
| NAPE(58:5p) | PI 36:2 | PS 38:4 | LysoPI 18:0 [M–H2O–M] | |||
| PI 36:1 | PE 36:3 | NAPE(52:5p) | PI 34:1 | |||
| Ki67 | NAPE(58:5p) | CL 74:10 | CL 74:10 | LysoPSp 18:1 | PI 36:2 | |
| CL 72:8 | CL 78:13 | LysoPSp 18:1 | PI 36:1 | PI 36:1 | ||
| CL 78:13 | LysoPA 18:1 [M–H2O–M] | FA_C22:1 | NAPE(58:6p) | PS 38:4 | ||
| CL 74:10 | CL 78:7 | CL 78:1 | FA_C22:1 | FA_C22:1 | ||
| PE 38:4 | NAPE(58:5p) | PI 36:1 | PI 36:2 | PI 34:1 | ||
| CD45 | CL 74:5 | CL 76:5 | CL 76:5 | CL 76:5 | PI 40:6 | CL 74:5 |
| CL 76:5 | CL 74:5 | CL 74:5 | CL 74:5 | CL 74:5 | CL 76:5 | |
| arginine | arginine | PE 38:3 | PI 40:6 | FA_C20:3 | PE 38:4 | |
| NAPE(56:5p) | NAPE(56:5p) | PE 38:4 | FA_C20:3 | CL 76:5 | PEp 40:5 | |
| GM3(16:0h) | PE 42:7 | hex(3)-hexNAc(3)-cer 44:1 | GM3(16:0h) | LysoPI 18:0 [M–H2O–M] | PEp 38:4 |
a
Matrix showing the top five known species that showed differences between two markers. Top species were identified using the VIP score from OPLS-DA analysis.